ROBERT S. EPSTEIN - 01 Oct 2025 Form 4 Insider Report for VERACYTE, INC. (VCYT)

Role
Director
Signature
/s/ Jonathan Wygant, as attorney-in-fact
Issuer symbol
VCYT
Transactions as of
01 Oct 2025
Net transactions value
-$673,804
Form type
4
Filing time
03 Oct 2025, 16:16:18 UTC
Previous filing
23 Jun 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
EPSTEIN ROBERT S Director 6000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO /s/ Jonathan Wygant, as attorney-in-fact 03 Oct 2025 0001252004

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VCYT Common Stock Options Exercise $79,400 +10,000 +14% $7.94 83,919 01 Oct 2025 Direct F1
transaction VCYT Common Stock Sale $753,204 -21,473 -26% $35.08 62,446 01 Oct 2025 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VCYT Stock Option (right to buy) Options Exercise $0 -10,000 -100% $0.000000 0 01 Oct 2025 Common Stock 10,000 $7.94 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 5, 2025.
F2 Represents weighted average sales price. Sale prices for the transactions range from $35.00 to $35.30. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.